Canopy’s stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.

Robert F. Kennedy Jr., seen as pro-cannabis, is heading toward expected approval as Health and Human Services secretary, ...

The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025.

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Medical announced the expansion of its medical cannabis extract portfolio in Germany. Tilray’s new medical cannabis offerings in ...

The wind-up of failed medical Aether Pacific Pharmaceuticals, formerly known as Medical Kiwi, commenced recently with an ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

Tilray, Aurora Cannabis, Canopy Growth, Turning Point Brands, and Innovative Industrial Properties are the five Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis ...

Fogel, a former US diplomat, is being released by Russia after 14 years for cannabis possession. The White House negotiated ...

Medical cannabis platform Vitura Health (ASX:VIT) has expanded its reach in the booming telehealth sector by acquiring the ...

CNBS's portfolio is less concentrated in a few stocks compared to MSOS, reducing risk. Check out why I rate the fund a buy.

Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.